Increased levels of MIF have been reported in many cancer types including pancreatic cancer (Tan et al., 2014), hepatocellular cancer (Huang et al., 2014) or head and neck cancer (Kindt et al., 2013). This evidence concerns the gene MIF and hepatocellular carcinoma.